Rodman & Renshaw Starts Keryx (KERX) at Market Outperform, $6 Price Target
Tweet Send to a Friend
Rodman & Renshaw initiates coverage on Keryx Biopharma (Nasdaq: KERX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
